Aetna is taking legal action against Pfizer, Novartis, Teva Pharmaceuticals and others, saying the list of drugmakers ...

In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...

This could start to bring down the cost of brand-name competitors—here's who may get to use it, and one major difference from ...

To close out the year, 4 senators came together to introduce a new bipartisan bill to protect biosimilar and generic drug ...

The Company has been granted Competitive Generic Therapy designation, which allows for 180 days of marketing exclusivity.

Patients would pay no more than $25 for certain name-brand medications to treat chronic illnesses, including insulin for ...

While a stuffy nose is a common side effect of oral ED medications, switching from Cialis to shorter-lasting options like ...

President-elect Trump’s plan to enact heavy tariffs on certain imports could affect the prices and availability of ...

The legislative rush provided another example of state lawmakers struggling to reach consensus on significant policy matters, ...

The fight against type 2 diabetes just reached a groundbreaking milestone. Last week, the U.S. Food and Drug Administration ...

The bill would add scrutiny to pharmacy benefit managers and eliminate or cap out-of-pocket costs for drugs that treat ...

Stay updated on the latest developments in the GLP-1 drug class, including a new generic entering the market, weight loss results, FDA decisions & cost issues.